Article

Multifocal IOLs deliver for carefully selected candidates

Patients should be made aware of the possibility of nighttimeissues with lights and glare and halo problems.

Istanbul, Turkey-An evaluation of two new multifocal IOLs-Tecnis MF and ReZoom by Advanced Medical Optics-indicated that both correct far, intermediate, and near vision and reduce the patient's dependency on glasses.

Patients were considered for refractive lens exchange (RLE) if they were less than 45 years old, had high myopia or hyperopia, and were not suitable candidates for either LASIK or implantation of phakic IOLs; patients who were older than 45 years with high myopia or low and high degrees of hyperopia and were not suitable candidates for LASIK; and those who were presbyopic. Contraindications to RLE are low myopia and high corneal astigmatism, Dr. Toygar explained.

In addition, Dr. Toygar advised that when considering implantation of a multifocal IOL, the patient should have relatively healthy eyes. Patients may be candidates if they have postoperative astigmatism of less than 1.5 D, postoperative emmetropia, or a maximum 0.75 D of hyperopia. The patients should also be highly motivated, such as those who wear high-diopter spectacles, those who are hyperopic, and those who want independence from spectacles. He also advised that the patient's profession be considered.

Patients were excluded if there were any macular pathologies or glaucoma with severe visual field loss, if they had undergone a previous corneal refractive surgery, if a monofocal IOL was already in one eye, if the expected astigmatism would exceed 1.5 D, and if the expected myopia would exceed 0.5 D.

Modified prolate

The Tecnis IOL has an anterior surface (modified prolate) that compensates for spherical aberration and the diffractive pattern is on the posterior side. The IOL is a three-piece UV-absorbing high-refractive silicone IOL with cut-off at 392 to 394 nm. It has a total diameter of 12 mm and an optic diameter of 6 mm. The lens is designed with a sharp optical edge to minimize posterior capsular opacification (PCO), he said.

The Tecnis was implanted in 37 eyes of 20 patients (nine women, 11 men) who ranged in age from 22 to 65 years (mean age, 47.38 ± 11.16 years) and were followed for 3 months. The preoperative spherical equivalent (SE) ranged from –15.50 to +7.5 D. Postoperatively, the spherical equivalent was –0.38 to +1.0 D.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.